THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUED UPON ITS EXERCISE ARE SUBJECT TO THE RESTRICTIONS ON TRANSFER SET FORTH IN SECTION 5 OF THIS WARRANTIntercept Pharmaceuticals Inc • September 4th, 2012 • Pharmaceutical preparations • New York
Company FiledSeptember 4th, 2012 Industry JurisdictionINTERCEPT PHARMACEUTICALS, INC., a Delaware corporation (the "Company"), for value received, hereby certifies that , or its registered assigns (the "Registered Holder"), is entitled, subject to the terms and conditions set forth below, to purchase from the Company, at any time or from time to time on or after the date of issuance and on or before 5:00 p.m. (New York City time) on October 24, 2013, shares of the Company's common stock, par value $0.001 per share, of the Company ("Common Stock"), at a purchase price of $0.50 per share. The shares purchasable upon exercise of this Warrant, and the purchase price per share, each as adjusted from time to time pursuant to the provisions of this Warrant, are hereinafter referred to as the "Warrant Shares" and the "Purchase Price," respectively.
THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUED UPON ITSIntercept Pharmaceuticals Inc • September 4th, 2012 • Pharmaceutical preparations • New York
Company FiledSeptember 4th, 2012 Industry JurisdictionINTERCEPT PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), for value received, hereby certifies that , or his registered assigns (the “Registered Holder”), is entitled, subject to the terms and conditions set forth below, to purchase from the Company, at any time or from time to time on or after the date of issuance and on or before 5:00 p.m. (New York City time) on May 4, 2014, shares of the Company's common stock, par value $0.001 per share, of the Company (“Common Stock”), at a purchase price of $0.50 per share. The shares purchasable upon exercise of this Warrant, and the purchase price per share, each as adjusted from time to time pursuant to the provisions of this Warrant, are hereinafter referred to as the “Warrant Shares” and the “Purchase Price,” respectively.
THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUED UPON ITS EXERCISE ARE SUBJECT TO THE RESTRICTIONS ON TRANSFER SET FORTH IN SECTION 5 OF THIS WARRANTIntercept Pharmaceuticals Inc • September 4th, 2012 • Pharmaceutical preparations • New York
Company FiledSeptember 4th, 2012 Industry JurisdictionINTERCEPT PHARMACEUTICALS, INC., a Delaware corporation (the "Company"), for value received, hereby certifies that , or its registered assigns (the "Registered Holder"), is entitled, subject to the terms and conditions set forth below, to purchase from the Company, at any time or from time to time on or after the date of issuance and on or before 5:00 p.m. (New York City time) on October 24, 2013, shares of the Company's common stock, par value $0.001 per share, of the Company ("Common Stock"), at a purchase price of $1.50 per share. The shares purchasable upon exercise of this Warrant, and the purchase price per share, each as adjusted from time to time pursuant to the provisions of this Warrant, are hereinafter referred to as the "Warrant Shares" and the "Purchase Price," respectively.